CSIMarket
 
Covetrus Inc.  (CVET)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 140
 Employees 5,000
 Revenues (TTM) (Millions $) 4,649
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -143
 Capital Exp. (TTM) (Millions $) 62

Covetrus Inc.
Covetrus Inc. is a global animal health technology and services company that was formed in February 2019 following the merger of two companies: Vets First Choice and Henry Schein Animal Health. The company is headquartered in Portland, Maine, and has offices and operations in more than 25 countries, serving veterinary practices, animal welfare organizations, and pet owners.

Covetrus offers a comprehensive suite of technology-enabled products and services that include software, pharmacy, and supply chain solutions, as well as diagnostic products, vaccines, and equipment. The company's technology platform provides veterinary practices with a suite of tools to manage their practice operations, patient care, and inventory. This platform, called Covetrus Connect, allows veterinarians to manage their practice data from anywhere and at any time, with a suite of integrated applications designed to make their lives easier.

One of Covetrus' unique offerings is its prescription management service, which simplifies the prescription-writing process for veterinarians and pet owners. The service allows veterinarians to send prescriptions directly to Covetrus, which will then contact the pet owner, handle the payment processing, and deliver the medication directly to them.

Covetrus also operates an online marketplace called Covetrus North America (CNA), which provides veterinary practices with access to a wide range of animal health products and supplies from more than 2,800 suppliers. The platform provides a streamlined ordering process, competitive pricing, and access to product information and customer support.

The company has also established relationships with pet owners and animal welfare organizations. Covetrus offers a range of products and services aimed at improving pet health and wellness, including prescription medications, over-the-counter remedies, and wellness products.

Since its establishment, the company has grown significantly, with more than 5,500 employees globally, generating $4 billion in annual revenue. Covetrus has a strong commitment to innovation and is constantly expanding its offerings to provide better solutions and support to its customers.


   Company Address: 7 Custom House Street Portland 4101 ME
   Company Phone Number: 280-2221   Stock Exchange / Ticker: NASDAQ CVET
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EB   -5.03%    
• View Complete Report
   



Hwh International Inc

HWH International Inc Sees Stable Revenue in Fourth Quarter of 2023, Slight Improvement in Earnings Per Share

The financial results for the fourth quarter of 2023 for HWH International Inc show a slight improvement in earnings per share compared to the previous year, but a decrease from the previous quarter. The revenue remained unchanged from both the previous year and the previous quarter. The company reported a net loss of $0.000 million for the quarter, which is a decrease from the corresponding quarter a year before.
Looking at the fiscal year 2023 as a whole, HWH International Inc reported revenue of $0.00 million and earnings of $0.55 million. This indicates that the company was able to generate profits for the year despite experiencing a loss in the fourth quarter.

Petiq Inc

2. Battling Losses: PetIQ Inc Struggles to Achieve Profitability Despite Impressive Revenue Growth

PETQ Reports Increased Loss Per Share for Recent Fiscal Period
EAGLE, Idaho, Feb. 07, 2024 - PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, announced its financial results for the fourth quarter and full year ended December 31, 2023. Despite some unfavorable numbers, the company remains optimistic about its future performance.
For the most recent fiscal period, PETQ reported a loss per share of $-0.60, compared to $-0.24 in the previous year. The Income per Share also fell from $0.02 to -$0.60 sequentially. However, there was a notable increase in revenue, which grew by 19.937% to $220.78 million from $184.08 million in the same quarter of the previous year.

Nu Skin Enterprises Inc

Nu Skin Enterprises Inc. Reports Significant Decline in 2023 Q4 Revenue and Profits, Raising Concerns About Financial Stability

Nu Skin Enterprises Faces Significant Revenue and Profit Declines in Q4 2023
Nu Skin Enterprises Inc. (NYSE: NUS) recently released its fourth quarter and full-year 2023 financial results, which showed a significant decline in revenue and profits. In the fourth quarter of 2023, the company's revenue decreased by a staggering -6.518% to $488.30 million, compared to $498.27 million in the previous quarter. This decline in revenue directly impacted the company's profits, which plummeted by -87.26% to $0.15 per share, down from $1.16 per share in the corresponding quarter one year ago.
The decline in revenue and profits is a cause for concern for Nu Skin Enterprises shareholders. The company's bottom-line also suffered, with a -87.27% decrease in net income from $57.215 million in the corresponding period a year before to $7.282 million in the fourth quarter of 2023. This significant decline in profits raises doubts about the company's ability to maintain its financial stability and sustainability.

Mckesson Corporation

Despite Strong Revenue, McKesson Corporation's Earnings Decline in Q3 2024

McKesson Corporation, a leading healthcare services company, has experienced a significant increase in its stock performance in recent months. Over the past three months, the company's stock has improved by 15.42%. However, during the month of February, the stock dropped by 2.94%. Despite this dip, McKesson Corporation's stock has reached its 52-week high.
One of the factors contributing to the fluctuation in McKesson Corporation's stock price is its financial performance. In the third quarter of the 2024 earnings season, the company experienced a decline in earnings per share (EPS) while revenue increased. EPS plummeted by -42.3% to $4.42 per share, while revenue showed an admirable increase of 14.765% to $80.90 billion compared to the same reporting season the previous year.

Cvs Health Corporation

CVS Health Corporation Sees Decrease in Fourth Quarter 2023 Earnings Amidst Impressive Revenue Growth

CVS Health Corporation, a leading Pharmacy Services and Retail Drugstore company, experienced a slight decline in its shares during the month of February 2024. The shares dropped by -0.22%, bringing the year-to-date performance to -8.77%. Currently trading on the NYSE, CVS Health Corporation's shares are valued at 1% above its 52-week average.
During the period from October to December 2023, CVS Health Corporation witnessed a reduction in its earnings per share (EPS) despite a significant increase in revenue. The profitability decreased by -9.26% to $1.59 per share, while the revenue grew extensively by 11.887% to $93.81 billion compared to the same period the previous year. This growth in revenue outpaced the top-line performance of most other companies in the Pharmacy Services and Retail Drugstore sector, as they reported an average revenue advance of 11.61% in the fourth quarter of 2023 compared to the previous year.






 

Covetrus's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com